Advertisement
Screener

XERIS BIOPHARMA HOLDINGS, INC. (XERS) ROA

XERIS BIOPHARMA HOLDINGS, INC. (XERS) ROA

  • 2026-06-30: ROA -4.17%.
  • 2026-03-31: ROA 3.06%.
  • 2025-12-31: ROA 0.14%.
  • 2025-09-30: ROA -4.22%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-4.17%
2026-03-313.06%
2025-12-310.14%
2025-09-30-4.22%
2025-06-30-9.56%
2025-03-31-14.29%
2024-12-31-16.97%
2024-09-30-19.66%
2024-06-30-17.96%
2024-03-31-19.13%
2023-12-31-19.30%
2023-09-30-18.85%
2023-06-30-21.73%
2023-03-31-24.20%
2022-12-31-27.48%
2022-09-30-43.73%
2022-06-30-42.90%
2022-03-31-40.88%
2021-12-31-40.32%
2021-09-30-71.46%
2020-12-31-57.27%

Annual ROA

DateROA
2025-12-310.14%
2024-12-31-16.97%
2023-12-31-19.30%
2022-12-31-27.48%
2021-12-31-40.32%
2020-12-31-57.27%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
Xencor Inc (XNCR)United States$1.776B-7.33
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Septerna, Inc. (SEPN)United States$1.783B-63.01